IRIS
TISONE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 83.229
AS - Asia 11.354
EU - Europa 7.751
SA - Sud America 1.532
Continente sconosciuto - Info sul continente non disponibili 943
AF - Africa 143
OC - Oceania 18
Totale 104.970
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 82.889
SG - Singapore 5.531
CN - Cina 2.231
RU - Federazione Russa 1.273
BR - Brasile 1.254
HK - Hong Kong 1.166
IT - Italia 1.150
UA - Ucraina 1.073
DE - Germania 1.047
VN - Vietnam 822
IE - Irlanda 815
FI - Finlandia 660
GB - Regno Unito 466
SE - Svezia 379
FR - Francia 336
BD - Bangladesh 334
KR - Corea 296
JP - Giappone 288
IN - India 197
CA - Canada 185
NL - Olanda 131
AR - Argentina 107
PL - Polonia 96
TR - Turchia 78
AT - Austria 73
ID - Indonesia 73
MX - Messico 71
ES - Italia 62
IQ - Iraq 57
ZA - Sudafrica 47
EC - Ecuador 44
BE - Belgio 36
CO - Colombia 34
CL - Cile 29
CZ - Repubblica Ceca 29
SA - Arabia Saudita 23
EG - Egitto 22
PK - Pakistan 21
PY - Paraguay 20
UZ - Uzbekistan 20
MY - Malesia 19
CH - Svizzera 18
AU - Australia 17
JM - Giamaica 17
AE - Emirati Arabi Uniti 16
GR - Grecia 15
IL - Israele 15
PH - Filippine 15
TH - Thailandia 15
JO - Giordania 14
KE - Kenya 14
RO - Romania 14
AZ - Azerbaigian 13
EU - Europa 13
MA - Marocco 13
NP - Nepal 13
VE - Venezuela 13
KG - Kirghizistan 12
TN - Tunisia 12
UY - Uruguay 12
DZ - Algeria 11
IR - Iran 11
KZ - Kazakistan 11
PE - Perù 11
TT - Trinidad e Tobago 11
CR - Costa Rica 10
HN - Honduras 10
LT - Lituania 10
MD - Moldavia 10
DO - Repubblica Dominicana 9
OM - Oman 7
BO - Bolivia 6
LB - Libano 6
NO - Norvegia 6
PT - Portogallo 6
BG - Bulgaria 5
GT - Guatemala 5
NG - Nigeria 5
SN - Senegal 5
TW - Taiwan 5
AL - Albania 4
AM - Armenia 4
HR - Croazia 4
HU - Ungheria 4
KH - Cambogia 4
KW - Kuwait 4
LV - Lettonia 4
MN - Mongolia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TM - Turkmenistan 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
AG - Antigua e Barbuda 3
BS - Bahamas 3
BY - Bielorussia 3
DK - Danimarca 3
DM - Dominica 3
LK - Sri Lanka 3
Totale 103.987
Salva come PNG Salva come JPEG
Città #
Woodbridge 22.646
Wilmington 21.024
Houston 18.736
Singapore 2.730
Fairfield 2.213
Ann Arbor 1.942
Ashburn 1.564
San Jose 1.231
Chandler 1.156
Hong Kong 1.142
Jacksonville 975
Seattle 965
New York 835
Cambridge 825
Beijing 824
Dublin 800
Medford 597
Santa Clara 501
Helsinki 409
The Dalles 392
Los Angeles 345
Rome 332
Dearborn 331
Council Bluffs 310
Zhengzhou 283
Lawrence 280
Ho Chi Minh City 260
Tokyo 231
Buffalo 224
Moscow 220
Hanoi 182
Mülheim 172
San Diego 147
São Paulo 139
Lauterbourg 126
Dallas 118
Milan 111
Orem 104
Chicago 97
Menlo Park 95
Elk Grove Village 93
Sunnyvale 88
Hangzhou 87
Boardman 80
Munich 75
Shanghai 71
London 70
Atlanta 67
North Bergen 67
Frankfurt am Main 65
Chennai 64
Jersey City 60
Montreal 60
Phoenix 60
Nuremberg 57
San Mateo 54
Creede 51
Redwood City 50
Guangzhou 49
University Park 49
Warsaw 49
Brooklyn 47
Manchester 47
Palo Alto 46
Mountain View 44
Amsterdam 43
Denver 43
Rio de Janeiro 43
Jakarta 41
Nanjing 41
Verona 41
Falls Church 39
Saint Petersburg 39
Johannesburg 38
Norwalk 38
San Francisco 38
Redondo Beach 36
Stockholm 36
Toronto 36
Columbus 35
Poplar 35
Hefei 33
Vienna 32
Da Nang 30
Kraków 30
Seoul 30
Brussels 28
Lappeenranta 28
Engelhard 27
Belo Horizonte 26
Haiphong 26
Salt Lake City 26
Washington 26
Mexico City 25
Kunming 24
Miami 24
Mumbai 24
Brasília 22
Turku 22
Curitiba 21
Totale 88.290
Salva come PNG Salva come JPEG
Nome #
Hepatitis C reinfection after liver transplantation in relation to virus genotype 613
Safety of complete and sustained prophylaxis withdrawal in patients liver-transplanted for HBV-related cirrhosis at low risk of HBV recurrence 591
Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression 586
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 578
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 558
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 535
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 529
Recurrence of insulin resistant metabolic syndrome following liver transplantation 510
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. 510
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 509
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 508
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization 507
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 502
Graft failure due to hemolytic uremic syndrome recurrence 499
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 499
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. 496
Operational tolerance in clinical liver transplantation: emerging developments. 492
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 492
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 491
Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. 491
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 488
Use of mycophenolate mofetil in liver transplantation: a literature review. 487
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 486
Ribavirin increases mitogen- and antigen-induced expression of CD40L on CD4+ T cells in vivo. 485
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft. 485
Bronchobiliary fistula treated by self-expanding ePTFE-covered nitinol stent-graft 484
Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers 481
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 478
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 477
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 475
Marginal donors in liver transplantation. 473
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 472
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 472
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation. 468
Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders 467
Infectious complications in renal transplant recipients 467
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 466
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 465
596 463
Interposition of the right colic angle between the liver and thoracic wall: an unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient. 461
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 460
Is nephrectomy indicated in uremic patients with ADPKD waiting for transplant? 459
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 457
Leptin attenuates ischemia-reperfusion injury in the rat liver. 457
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 455
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 452
Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases. 452
Clinical and neurophysiological evidence of polyneuropathy in liver transplant candidates: preliminary report. 451
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study 451
Management of spermatic cord liposarcoma in renal transplant recipients: case report 449
10-28 year follow-up in 23 patients with kideny traansplantation: immunosuppressive therapy, survival and complications 449
Liver abscess caused by foreign body ingestion 447
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 446
Multiparameter immune profiling of operational tolerance in liver transplantation. 446
Graft failure due to hemolytic uremic syndrome recurrence 446
A randomized trial of everolimus and low-dose cyclosporine in renal transplantation: With or without steroids? 446
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial. 445
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 445
Quality of life and long-term follow-up after kidney transplantation: a 30-year clinical study. 444
Flow cytometric analysis of antidonor-specific antibodies in liver transplant. 443
Phase I clinical trial with the AMC-bioartificial liver. 442
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation. 442
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 441
Interposition of the right colic angle between the liver and thoracic wall: An unusual cause of massive rectal bleeding following percutaneous biopsy in a liver transplant recipient 440
Ureteral obstruction in 140 renal transplant patients: preventions and treatment 440
Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient: a case report. 439
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 439
Reduced acute rejection and side effects with neoral in liver transplantation. 438
Sequential changes in serum and biliary bile acids after liver transplantation 437
Retrospective analysis of 30 patients who underwent liver transplantation without use of steroids 437
Immunosuppression-Free Liver Transplantation 437
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C 437
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 436
Liver transplantation for end-stage liver disease related to viral hepatitis 435
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins 435
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 434
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. 434
Split-liver transplantation with pediatric donors: a multicenter experience. 432
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 432
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 432
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C 431
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 431
Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. 430
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 429
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 429
Clinical Significance of de novo production of HLA of donor-specific antibodies in kidney transplantation. 428
Average results and follow-up in 11 over-60 years of age kidney transplanted patients 428
Gravity perfusion versus high-pressure perfusion in kidney transplantation: results from a prospective randomized study. 428
Surgical versus percutaneous technique for veno-venous bypass during orthotopic liver transplantation: a prospective randomized study. 427
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 427
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. 427
Spontaneous resolution of severe acute rejection in liver transplantation. 425
Liver transplantation in the presence of portal vein thrombosis: report from a single center. 425
[An unusual case of ureteral obstruction after kidney transplantation]. 425
Characterization of γδ T cell subsets in organ transplantation. 424
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation 424
Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. 423
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 423
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 423
2.0 J Ti:sapphire laser oscillator. 422
Totale 46.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 256.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 256.091
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.699 0 300 92 159 78 324 133 118 264 307 123 801
2022/20233.506 372 283 80 362 270 795 322 323 295 23 291 90
2023/20241.299 145 41 187 25 137 306 52 40 31 65 23 247
2024/20258.227 253 1.656 822 476 137 569 592 304 746 624 1.162 886
2025/202613.616 1.019 683 1.334 1.341 1.224 827 1.761 1.790 1.435 1.082 642 478
2026/20271.068 676 392 0 0 0 0 0 0 0 0 0 0
Totale 104.970